Share capital, stock options and other stock-based plans - Share units (Details) - Share units - $ / shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Number of Units | ||
| Outstanding, beginning of period (in shares) | 713,061 | 524,322 |
| Granted (in shares) | 130,000 | 137,151 |
| Exercised (in shares) | (20,521) | (68,071) |
| Forfeited/expired (in shares) | (134,706) | (117,296) |
| Outstanding, end of period (in shares) | 687,834 | 476,106 |
| Units outstanding and exercisable, end of period (in shares) | 491 | 491 |
| Weighted average grant date fair value (CDN $) | ||
| Outstanding, beginning of period (in Canadian dollars per share) | $ 11.75 | $ 11.75 |
| Granted (in Canadian dollars per share) | 2.02 | 3.99 |
| Exercised (in Canadian dollars per share) | 17.80 | 17.48 |
| Forfeited/expired (in Canadian dollars per share) | 8.55 | 11.36 |
| Outstanding, end of period (in Canadian dollars per share) | 5.20 | 8.78 |
| Units outstanding and exercisable, end of period (in Canadian dollars per share) | $ 31.07 | $ 31.07 |
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding and exercisable, including both vested and non-vested instruments. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-option equity instruments exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-option equity instruments cancelled/expired. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant date fair value of non option equity instruments granted during the period. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-option equity instruments outstanding and exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-option equity instruments outstanding. No definition available.
|
| X | ||||||||||
- Details
|